Alectinib for untreated ALK-positive advanced non-small-cell lung cancer

Equality Impact Assessment (Guidance development) (PDF 234 KB)

Final appraisal determination

Final appraisal determination document (PDF 388 KB)

Committee papers (PDF 2.46 MB)

Public committee slides (PowerPoint 107 KB)

Draft guidance: 1

Appraisal consultation document (PDF 404 KB)

Committee papers (PDF 11.31 MB)

Public committee slides Clinical slides (PDF 593 KB)

Public committee slides Cost slides (PDF 819 KB)

Final scope (PDF 232 KB)

Draft scope and provisional matrix comments table (post-referral) (PDF 255 KB)

Final matrix (PDF 335 KB)

Equality impact assessment (Scoping) (PDF 172 KB)

Draft scope post referral (PDF 358 KB)

Draft matrix post referral (PDF 339 KB)